BB Biotech AG (BBAGF)
- Previous Close
47.23 - Open
47.23 - Bid --
- Ask --
- Day's Range
47.23 - 47.23 - 52 Week Range
47.23 - 57.70 - Volume
61 - Avg. Volume
101 - Market Cap (intraday)
3.627B - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
-- - EPS (TTM)
-17.29 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
www.bbbiotech.ch/en/bb-biotech/10
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: BBAGF
Performance Overview: BBAGF
Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BBAGF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BBAGF
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-0.76%
Return on Equity (ttm)
-8.25%
Revenue (ttm)
35k
Net Income Avi to Common (ttm)
-206.61M
Diluted EPS (ttm)
-17.29
Balance Sheet and Cash Flow
Total Cash (mrq)
2.64B
Total Debt/Equity (mrq)
13.12%
Levered Free Cash Flow (ttm)
-22.32M
Company Insights: BBAGF
BBAGF does not have Company Insights